With the acquisition of Mound Laser, Resonetics will now expand beyond its current focus on polymers and glass and offer customers a broader array of solutions and material expertise. In addition to long-standing core competencies in laser welding, cutting and machining, Mound Laser has developed expertise using the latest ultrafast laser technologies. The company has also conducted extensive research in micro additive manufacturing and plans to introduce new, proprietary tools that will help medical device designers as they continue to create ever smaller, complex products that challenge the limits of conventional machining and joining technologies.
“The team at Mound Laser has made impressive strides in recent years, taking on very difficult-to-manufacture components in the neurovascular, structural heart and peripheral vascular markets in particular,” said Tom Burns, Resonetics CEO. “The two companies share similar cultures built upon innovation, responsiveness, integrity and a passion for service. We’re excited about the combined technology, know-how and experience that we can now deploy across a wide range of materials in many of the fastest growing segments of the life sciences industry.”
“Resonetics has had great success building a leadership position in laser micro machining of polymers,” added Kevin Hartke, President and Chief Operating Officer of Mound Laser. “Our focus has always been on developing novel laser processes to manufacture the most challenging product features cost-effectively. With Maric Management’s investment and leadership the past two years, Mound Laser made strategic advancements in its medical manufacturing capabilities. The additional resources, experience and infrastructure provided by Resonetics will enable us to move even faster in meeting more of our customers’ needs.”
With the acquisition, Resonetics believes it has the world’s largest capacity of ultrafast laser workstations serving the life sciences industry and can offer customers redundancy with manufacturing sites in the Eastern, Western and Central United States.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.